decrease of the in vitro drug-metabolizing activity of the hepatic mixed function oxidase system in...
TRANSCRIPT
Pharmacological Research Communications, VoL 13, No. 8, 1981 731
DECREASE OF THE IN VITRO DRUG-METABOLIZING ACTIVITY OF THE
HEPATIC MIXED FUNCTION OXIDASE SYSTEM IN RATS INFECTED
EXPERIMENTALLY WITH FASCIOLA HEPATICA: PHARMACOLOGICAL
IMPLICATIONS.
Roberto MAFFEI FACINO °, Marina CARINI °, Raffaele BERTULETTI °,
Claudio GENCHI °o and Alessandra MALCHIODI °°.
o Istituto di chimica Farmaceutica e Tossicologica
Viale AbrUZzi 42, 2Oi31 Milan, Italy.
oo Istituto di Patologia generale Veterinaria
Via Celoria 10, 20133 Milan, Italy.
Received in final form 19 May 1981
AOSTRACT
The e f f e c t s o f experimental i n f e c t i o n w i t h F a s c i o l a h e p a t i c a
on the in v i t r o drug-metabol iz ing a c t i v i t y of the hepatic
mixed funct ion oxidase (MFO) system have been studied in the
r a t . D e c r e a s e s i n c y t o c h r o m e P - 4 5 0 - d e p e n d e n t m e t a b o l i z i n g
activities (p-nitroanisole O-demethylase, aminopyrine
N-demethylase, hexobarbital oxidase, aniline hydroxylase
and zoxazolamine hydroxylase) are observed throughout the
infection period and are maximal in t~e acute stage.
The decreases are consequent to decreased cytochrome P-450
and NADPH-cytochrome P-450 (cytochrome c) reductase.
The depressed drug-metabol iz ing a b i l i t y of the l i v e r
monooxygenase system might alter the steroids and fatty
acids catabolism in the liver cell and decrease the
safety margin for those flukicidal agents that are
de tox i f i ed by the monooxyoenase pathway.
0031-6989/81/080731-12/$02.00/0 ©1981TheltahanPharmacologicalSociely
732 Pharmacol~alResearchCommun~at~ns, VoL13, No. 8,1981
INTRODUCTION
I t has been e s t a b l i s h e d f o r t h e mouse and t h e r a t ( T h o r p e ,
l g 6 5 ; Rahko , 1971 ) t h a t t h e i n t r a h e p a t i c m i g r a t i o n o f
F a s c i o l a h e p a t i c a , an u b i q u i t o u s h e l m i n t h p a r a s i t e o f
mammals, d u r i n g t h e i n c u b a t i o n p e r ~ o d ( 2 - 1 7 d a y s ) and
t h e a c u t e p e r i o d ( 1 7 - 3 2 d a y s ) o f t h e i n f e c t i o n i n d u c e s
s e v e r a l k i n d s o { m o r p h o l o g i c a l damage t o t h e l i v e r c e l l ,
i n c l u d i n g a l t e r a t i o n s o f t h e e n d o p l a s m i c r e t i c u l u m ( R z h k o ,
1 0 7 1 ) .
The smooth e n d o p l a s m i c r e t i c u l u m o f t h e mammal ian l i v e r
c e l l c o n t a i n s t h e c y t o c h r o m e P - 4 5 0 - d e p e n d e n t m i x e d f u n c t i o n
o x i d a s e (MFO) s y s t e m , an e l e c t r o n t r a n s p o r t p a t h w a y w h i c h
plays a key role in the oxidative metabolism of a variety
o? exogenous compounds (EstabrooK and Werringloer, 1977)
and is involved in the physiological oxidation of steroids,
fatty acids and cholesterol (Okit& et al., lgTg; Bjorkheim,
1 0 7 2 ) .
The p r e s e n t s t u d y w a s u n d e r t a k e n to e x a m i n e t h e e f f e c t s
o f an e x p e r i m e n t a l F a s c i o l & h e p a t i c a i n f e c t i o n on t h e
i n v i t r o d r u g - m e t a b o l i z i n g a c t i v i t y o f t h e l l e p a t i c NIFO
s y s t e m i n t h e r a t .
r.!ATE~IALS
All the substrates used were analytical orade.
NAOPII and c y t o c h r o m e c v:ere p u r c h a s e d f r o m 0 o e h r i n g e r
L ; i o c h e m i a R o b i n ( L ; i l a n , I t a l y } , 0 p e o t r o p h o t o m e t r i c s t u d i e s
v~cre c a r r i e d o u t i n ~ beckl.~&n D~-GT s p e c t r o p h o t o m e t e r .
The G e t a c e r c a r i a e u~ed t o i n f e c t t h e r a t s ~ e r e r e c o v e r e d
f r o ~ L/~m~ea t r u n c a t u l a , m a i n t a i n e d by a r t i f i c i a l c u l t u r e ,
Pharmacolog~alResearchCommun~atmns, VoL13, No.~ 1981
~IETHODS
733
Experimental i n f e c t i o n
30 ~ale Sprague-Dawley rats (Charles River) weighing 120 +
I0 g were infected orally with 25 metacercariae each.
The in fected animals and ti le con t ro l s were fed "ad
l i b i t u m " wi th commercial complete dry food and 6 animals
of each group were k i l l e d &t 10 day i n t e r v a l over a 40
dab, per iod and at the 60th day a f t e r the i n f e c t i o n .
The l i v e r s were immediately removed and weigl~ed and the
f lukes removed by d i ssec t i on of the parenshyma and b i l e
ducts of the infected animals. Liver tissue homogenates
were subsequently s u b j e c t e d to d i f f e r e n t i a l c e n t r i f u g a t i o n
(Raffaeli et El., 1977) .
Tissue preparat ion
61icrosomes from in fec ted and con t ro l l i v e r s were prepared
by the methods p rev ious l y described (Ra f f ae l i et a l . , 1377)
and suspended in 0. I~ phosphate buffer, pH 7.4, to a final
concentration of 2.0 mg protein/ml for the assay of the
monooxygenase activities.
Microsomal protein was determined by tile method of Lowry
et al. (1951); cytochrome P-450 and cytochrome b 5 by the
method of Omura and Sato (1Q64).
~nzyme agsays
The monooxygenase activities were determined by the methods
reported in l i t e r a t u r e : p - n i t r o a n i s o l e O-demethylase
( N e t t e r and S e i d e l , 1964)., a m i n o p y r i n e N - d e m e t h y l a s e (Coch in
and Axelrod, 1950), hexobarb i ta l oxidase (Cooper and Urodie,
IC,55), a n i l i n e hydroxylase (Imai et a l . , 1966) and zoxazolamine
hydroxylase (Conney et a l . , 19G0).
734 PharmacologicalResearchCommunications, Vol. 13,No.& 1981
The m o n o o x y g e n a s e a c t i v i t i e s were e x p r e s s e d i n nmo les p r o d u c t
f o r m e d ( p - n i t r o p h e n o l , f o r m a l d e h y d e and p - a m i n o p h e n o l ) o r
substrate disappearing (hexobarbital and zoxazolamine)/min/
mg microsomal protein.
NADPH-cytocllrome c reductase a c t i v i t y was assayed by
the method of P h i l l i p s and Langdon (Ig62) with cytochrome
c as the f i n a l e lec t ron accepter.
Contro l values were determined whenevee Fasciqla heAatica
in fec ted animals were k i l l e d because of we l l - recogn ized,
day-to-day v a r i a t i o n s in hepat ic microsomal enzyme a c t i v i t y
(Valer ino et a l . , 1074).
RESULTS
The body w e i g h t s ( T a b l e I ) o f F a s c i o l a h e p a t i c a i n f e c t e d rats
did not significantly vary from those of uninfected controis.
Absolute liver weiohts increased at the 20th day, and the
variation was maximai at the 30th day (TabIe I); after this
period, when the fiukes begin to localize in the main bile
ducts of the host , the absolute l i v e r weights tend to decrease
to the con t ro l values. The increase in the absolute l i v e r
weight observed in the acute phase of the i n f e c t i o n might
be due, as p rev ious ly demonstrated fo r the mouse and the nat,
to an increase in the p r o l i f e r a t i v e a c t i v i t y of l i v e r
parenchymal c e l l s , in reply to the l i v e r t issue damage
induced by the Fascio la hepatica migra t ion {Thorpe, 1965;
Rahko, 1971).
20-30 days a f t e r the i n f e c t i o n , ra ts sllow a decrease in
microsomal p ro te in content (mg/g fresh l i v e r ) , which tends
to become corrected a f t e r the 40th day (Table I ) .
TABLE I
Oo
dy
, li
ve
r w
eig
hts
a
nd
microso~nal
pro
tein
in
rats
in
fec
ted
e
xp
eri
me
nta
lly
wit
h
Fa
sc
iola
h
ep
ati
ca
a
t th
e
va
rio
us
po
sti
nfe
cti
on
al
da
ys
.
c~
DAY
10
20
30
~0
GO
BO
DY
~
EIG
t{T
(g
) L
IVE
R
V!E
IGI{
T
(g)
Controls
Infected
p
17
5.0
+
8
.0
17
7.5
+
9
.3
n.s
,
24
0.3
+
8
.3
23
7.0
+
9
.8
n.s
.
29
5.5
+
9
.8
30
0.4
+
7
0 n
,s.
34
7.0
+
8
.5
35
0.0
+
9
.7
n.s
.
45
0.5
+
1
2.0
4
60
.0
+
9.5
n
.s.
Controls
Infected
p
6.4
5
4-
0.3
4
6.7
+
0
.35
n
.s.
7.3
8
+
0.2
8
9.9
+
0
.27
~
&~
8.8
2
+
0.3
5
13
.7
+
1.1
0
~&
9.4
0
+
0.3
6
11
.3
+
0.4
5
~
14
.9
+
0.7
2
15
.2
+
0.5
0
n.s
.
RE
LA
TIV
E
/.ilC
RO
SO
[,IA
L
PR
OT
EIN
(mg
/g
liv
er)
--
..
.,
.
Co
ntr
ols
In
fec
ted
p
20
,75
~
0
.35
2
0.1
5
+
0.2
8
n.s
.
22
.25
~
0
.36
1
8.2
5
+
0.3
0
~
25
,80
~
0
.38
1
2.6
0
+
0.1
6
~$
~
26
.60
4-
0
.42
2
0.7
3
+
0.4
0
~,
Each value represents
the mean _+ S.E.
relative
to six animals.
P<
0
.00
27
.44
+
0
.32
2
6.7
0
+
0.4
0
~
c) }
~ P
<
0.0
1
,~ ~
P< 0.001
n.s.
not sionifican t
~4
736
F I G . I
Pharmacological Research Communications, VoL f 3, No. 8. 198f
12
o 08
EF 0.
" - ~ - " e6 •
C 10 20 30 40 O0
days
250
200 • &
100 - ~E
50 ~_~
Z~
C y t o c h r o m e P - 4 5 0 , b 5 and N A O P H - c y t o c h r o m e c r e d u c t a s e
activity in r a t s experimentally infected w i t h
Fasciola hepatica.
C y t o c h r o m e P-450 (- ); cytochrome b 5 ( - . - - - ) ;
NADPH-cytochrome c reduct&se a c t i v i t y ( - - - - - ) .
C r e p r e s e n t s t h e c o n t r o l v a l u e , mean + S . E . o f tt~e
values _+ ., o.E. r e l a t i v e to each .group of uninfected
animals.
& P{ O. 05
~ P ( O . 0 1
~ P<O. OO1
C y t o c h r o m e P-4DO, c y t o c h p o m e b_ and N A D P H - c y t o c h r o m e c
r e d u c t a s e a c t i v i t y
C y t o e h r o m e P - 4 5 0 and N A D P H - c y t o c h r o m e C r e d u c t a s e a c t i v i t y
in parasitized liver are slightly but significantly decreased
( P < O . O 5 ) on t h e 1Oth day a f t e r the i m f e c t i o n ; t h e two m a i n
c o m p o n e n t s of the e lect ron t ranspor t chain continue to
decrease u n t i l the gOth gay, at which time the leve ls ape
on1~y about bO'i of the cont ro l values ( F i g . l ) .
Cytoehrome P-450 and NADPl4-cytochrome c .reductase a c t i v i t y
Pharmacological Research Commun/cat/ons, Vo/. 13, No. 8, 1981
a r e s t i l l b e l o w t i l e c o n t r o l v a l u e s (85,% and gO~) on t h e
00th day of the infection.
C y t o c h r o m e b 5 c h a n g e s i n t h e same way as c y t o c h r o m e P - 4 5 0 ,
a l t h o u g h l e s s s t r i k i n g l y : 7 0 % on t h e 3 0 t h day and 95~,; on t h e
OOtl~ day (Fig.l).
737
C y t o g h r o m e . . P - 4 5 0 c . d e p e n d e p t m e . t a b o l i z . i n g _ ~ q t i v i t i e s
As r e p o r t e d i n F i g . 2A, on t h e l O t h day o f t h e i n f e c t i o n a l l
t h e c y t o c h r o m e P - A i O - d e p e n d e n t m e t a b o l i z i n g a c t i v i t i e s were
s i g n i f i c a n t l y d e c r e a s e d : t h e h e × o b a r b i t a l o x i d a s e , p - n i t r o -
a n i s o l e O - d e m e t h y l a s e and a m i n o p y r i n e N - d e m e t h y l a s e a c t i v i t i e s
were t h e more s e n s i t i v e t o Fa.§ .c io la h e p a t i c a damage (45-50%
o f t h e c o n t r o l v a l u e s ] .
The m o n o o x y g e n a s e a c t i v i t i e s p r o g r e s s i v e l y . . d e c r e a s e a u n t i l
t h e 3 0 t h d a y , a t w h i c h t i m e t h e h e x o b a r b i t a l o x i d a s e ,
p-nitroanisole O-demethylase and aminopyrine N-demethylase
had f a l l e n t o 10~ o f t h e c o n t r o l v a l u e s ,
The aniline and zoxazolamine hydroxylase activities were
less affected by Fasciola hepatica infection (90~ on the 10tl~
d a y ; 00~6 and 50% o f t h e c o n t r o l v a l u e s on t h e 3 0 t h day
o f t h e i n f e c t i o n ) ( F i g . 2 B ) .
The r e s t o r a t i o n o f t h e m o n o o x y g e n a s e a c t i v i t i e s had begun
by t h e 4 0 t h day o f t h e i n f e c t i o n . We w i s h to e m p h a s i z e t h a t
on t h e 5 0 t h d a y , when t he m i g r a t o r y s t a g e i n t o tl~e l i v e r
o a r e n c h y m a had l o n g beam f i n i s h e d and a l l t h e f l u k e s were
l o c a l i z e d i n t h e b i l e d u c t s ( T h o r p e , 1 9 6 5 ) , a l l o f t h e
m o n o o x y g e n a s e a c t i v i t i e s , e s p e c i a l l y I ~ e x o b a r b i t a l o x i d a s e
and p - n i t r o a n i s o l e O ~ d e m e t h y l a s e Were s t i l l l o w .
DISCUSSION
The m i x e d f u n c t i o n o x i d a s e o f t h e e n d o p l a s m i c r e t i c u l u m i s
r e s p o n s i b l e f o r t h e d e t o x i f i c a t i o n m e c h a n i s m s o r t h e l i v e r
738 Pharmacolopical Research Communications, Vol. 13, No. 8, 1981
0 ~ ~2 Z
I0
~ o6 g~ 4~ o,
~ 04
6 o,
A
,
l i t
B
k - . i ~ 1 l o p
120
I00 .%.,
40 ~&
,o f,:
C I0 20 30 40 60
cloys
FIG.2 Cytochrome P-450-dependent metabo l i z ing a c t i v i t i e s in
r a t s e x p e r i m e n t a l l y i n fec ted w i th Fa.scigla ' h..epatica.
A) I I/~xobanbital oxidase ( - - ) ; p - n i t r o a n i s o l e O-demethylase
( - - - - - ) ; aminopyr ine N-demethylase ( . . . . . ).
3) A n i l i n e hydroxy lase ( ..... ); zoxazolamine hydroxy lase
( - - - - - ) . C represents the c o n t r o l va lue, mean + S.E.
of t l le values _+ S.E. r e l a t i v e to each group of
un in fec ted animals.
P< O. O5
• P<O. 01
~ $ P<O.O01
ceil, and for the physiological oxidation of steroids and
f a t t y ac ids.
The f unc t i on of the e l ec t r on t r anspo r t chain of the ~F0
system depends on the f u n c t i o n of the f l a v o p r o t e i n , NADPH-
cytochrome P-450 (cytochrome e) reductase, respons ib le in
t l le endoplasmic r e t i c u l u m fo r the d i r e c t t r a n s f e r of
electrons from I~ADP}t to cytochrome(~) P-450, a family
PharmacologicalResearchCommun~ation~ Vol. 13, No.~ 1981
o f h e m o p r o t e i n s w h i c h s e r v e as t e r m i n a l o x i d a s e s ,
The p r e s e n t s t u d y d e m o n s t r a t e s t h a t d u r i n g t h e i n c u b a t i o n
period (2-17 days) the intrahepatic migration of Fasciola
hepatica induces a remarkable loss in the metabolic activity
of the MFO system on its typical substrates: this loss is
quite dram&tic in the acute period.
The beginning of the biliary stage (40th day) coincides with
a slight recovery of the MFO activity.
The activity is however still significantly depressed in the
chronic phase of the infection (40-60 days), when the absolute
liver weight and the microsomal proteins have already returned
to r ange of the con t ro l values.
The depression in rAFO a c t i v i t y is the consequence of decreases
in the monooxygenase enzymes, cytochrome P-450, cytochrome b b
and NADPH-cytochrome P-450 (cytochrome c) red,uctase.
The Fa l l in monooxygenase p ro te in might be lhe consequence
of d i r e c t l i v e r c e l l damage induced by Fasciola .hePatica
migra t ion - - u l t r a s t r u c t u r a l a l t e r a t i o n s of endoplasmic
re t i cu lum have been observed (Rahko, 1971).
I t might also be the r e s u l t of an increased p r o l i f e r a t i v e
response of the damaged t i ssue (see the increase in absolute
l i v e r weights) , which i s in accord wi th previous s tud ies
demonstrating tha t hepat ic monooxygenase enzymes are
decreased in any s i t u a t i o n in which there is an increased
rate of c e l l u l a r p r o l i f e r a t i o n , as in regenerat ive growth
a f t e r p a r t i a l hepatectomy, in f avou r ,o f spec ia l i zed p ro te ins
of the m i t o t i c sp ind le (Henderson and Kersten, 1969).
Ooth hypoteses are being i nves t i ga ted .
The decrease in cytochrome P-450-dependent metabol iz ing
a c t i v i t i e s in the pa ras i t i zed l i v e r c e l l s is of remarkable
i n t e r e s t , since i t might lead to an accumulation of
endogenous ( s t e r o i d s , f a t t y acids) and exogenous substrates
in the liver cell, with obvious physiological and toxicological
739
740 PharmacologicaI Research Communications. VoL 13, No. 8. 1981
c o n s e q u e n c e s . I n t h i s c o n n e c t i o n , i f t h e phenomenon (and
p r e l i m i n a r y e x p e r i m e n t s s6em t o c o n f i r m i t ) a l s o o c c u r s
i n a n i m a l s p e c i e s o£ e c o n o m i c i m p o r t a n c e ( s h e e p and c a t t l e ) , I
f l u k i c i d a l ' d r u g s w h i c h a r e e x t e n s i v e l y d e t o x i f i e d by
c y t o c h r o m e P - 4 5 0 (Gram e t a l . , 1 0 7 7 ) , mus t be g i v e n w i t h
c a u t i o n d u r i n g t h e a c u t e p e r i o d o f i n f e c t i o n , s i n c e
a~cumul&tion of the flukicid&l in the liver cell might
decrease its safety margin.
In addition, tl~ose flukieidal agents that, as untoward
effect, inhibit monooxygenase activities should be also
avoided, i.e., hexachlorophene, which has been shown
i n v i t r o to' c a u s e a l o s s o f c y t o c h r o m e P - 4 5 0 f r om r a t
l i v e r m i c r o s o m e s and t o i n h i b i t t h e m o n o o x y g e n a s e a c t i v i t i e s
b o t h i n v i t r o and i n v i v o ( G a n d o l f i e t a l . , 1974; C o n d i e
and G u h l e r , l g 7 g ) . i
For these reasons, the need for studies of\i_n vitro
metabolisr.~ of the commonest flukicidal agents, to determine
the enzyme system involved in their degradation, becomes
of striking importance.
In addition, the remarkable sensitivity of hexobarbital
m e t a b o l i s m i n v i t r o i n a l l s t a g e s o f t h e d i s e a s e , makes
t h i s compound s u i t a b l e f o r t e s t i n g f l u k e h e p a t o t o x i c i t y
i n v i v o (Conney e t a l . , 1960; Hansen and F o u t s , 1968;
t ~ a n n e r i n g , 1 9 6 8 ) .
P r o l o n g a t i o n o f t h e h e x o b a r b i t a l s l e e p i n g t i m e o r o f t h e
p l a s m a h e x o b a r b i t a l h a l f - l i f e i n F a s c i o l a h e p a t i c a i n f e c t e d
r a t s m i g h t be an i n v i v o e x p r e s s i o n o f t h e d e c r e a s e d
h e x o b a r b i t a l m e t a b o l i s m o b s e r v e d i n v i t r o .
This might serve as an index of the severity of the liver
damage caused by Fasciola hepatica, while the recovery
toward normal of these parameters would be an index of
the t l ;erapeut ic e f fec t iveness and safety of tl~e f l u k i c i d a l
a,lcnt,
Pharmacological Research Commun~ations, VoL 13, No. 8, 1981
REFERENCES
- B J O R K H E I M I . , E u r . . ) . 8 i o c h e m . , 2 7 , 354 ( 1 9 7 2 ) .
- C O C H I N ,J. and AXELROD ,J . , ,J. P h a r m a c o l . Exp. T h e r . , 12__~5,
105 ( 1 9 5 9 ) .
- C O N D I E L.W. and BUHLER D. R . , B i o c h e m . P h a r m a c . , 2 8 , 375
( 1 9 7 9 ) .
- CONNEY A . H . , DAVTSON C . , GASTEL R. and DURNS J . , J . ,
,J. P l~a rmaco l . Exp. T h e r , , 1 3 0 , 1 ( 1 9 6 0 ) .
- CONNEY A . H . , TROUSOF N. and 8URNS ,J .d . , ,J. P h a r m a c o l .
Exp. T h e r . , 128~ 335 ( 1 0 6 0 ) .
- COOPER ,J.R. and BRODIE D . D . , ,J. P h a r m a c o l . Exp. T h e r . ,
114 , 400 ( 1 9 5 5 ) .
- ESTADROOK R.W. and %'ERRINGLOER ,J . , Drug t, l e t a b o l i s m
C o n c e p t s (Ed. by , J e r i n & D . M . ) , p . 1 , A m e r i c a n C h e m i c a l
S o c i e t y , " V a s h i n g t o n (1 -377) .
- GANDOLFI A . , J . , NAKAUE H.S. and BUFILER D . R . , B /ochem.
P h a r m a c . , 2 3 , 1997 ( 1 9 7 4 ) .
- GRAt4 T . E . , STKIC G . , J . , LITTERST C . L . and MIt4NAU~H E . G . ,
t 4 i c r o s o m e s and Drug O x i d a t i o n s (Ed. by U l l r i c h e t a l . )
p . 5 2 7 ~ Pergamon P r e s s ( 1 9 7 7 ) .
- HANSEN A.R. and FOUTS J . R . , T o x i c . A p p l . P h a r m a c . , 13 ,
212 ( 1 9 0 8 ) o
- HENDERSON R , T . and KERSTEN K . J . , B i o c h e m . P h a r m a c . , 1 8 ,
2O87 ( 1 9 6 9 ) .
- I t4AI Y . , ITO A. and SATO R . , ,J. B i o c h e m . . Jap . , 6 0 , 417 (1,.366).
- LO;'/RY O . H . , ROSEBI{OUGH N . J . , FARR A . L . and RANDALL R . 4 . ,
J . ~ i o l . Ct ]em., 1 9 3 , 265 ( 1 9 5 1 ) .
- [4ANNERING G . . J . , S e l e c t e d P h a r m a c o l o g i c & l T e s t i n g M e t h o d s ,
(Ed. by C u r g e r A. ) , V o t . 3 , p . 5 1 , , ' . :arcel D e k k e r , New Y o r k
( 1 9 0 8 ) .
- NETTER K.,J. and SEIDEL G° , J . P h a r r n a c o [ . Exp. T h e r ° ,
146, 01 ( 1 9 0 4 ) .
741
742 Pharmacological Research Communications, Vol. 13, No. 8, 1981
- OKITA R . I . , JAKOBSSON S .W. , Pt{OUGH R.A. and SILER
h*.ASTERS B . S . , B i o c h e m . P h a r m a c . , 2 8 , 3385 ( 1 9 7 9 ) .
- O M U R A T. and SATO R . , .J. B i o l . Chem. , 239 , 2379 ( 1 9 6 4 ) .
- P H I L L I P S A.H. and LANGDON R . G . , .J. B i o l . Chem. , 23_~7,
2652 ( 1 9 6 2 ) .
- RAFFAELI E . , h~AFFEI FACINO R . , SAL~.ONA M. and P ITRE ' D . ,
Pharmac . Res. Commun., 9 , 833 ( 1 9 7 7 ) .
- RAHKO T . , Ann. A c a d . S c i . F e n n i c a e , 148 , 24 ( 1 9 7 1 ) .
- THORPE E . , J . Comp. P a t h . , 75 , 39 ( 1 9 6 5 ) .
- VALERINO D . M . , VESELL E . S ° , AURORI K .C. and .JOHNSON A . O . ,
D rug , tT, e t a b . D i s p o s ° , 2 , 448 ( 1 9 7 4 ) .